153 related articles for article (PubMed ID: 21601849)
41. Endogenous gonadotropin flare following microdose leuprolide (MDL) stimulation protocol does not correlate with in vitro fertilization (IVF) outcome.
Mann JS; Engmann L; Benadiva CA; Nulsen JC
Fertil Steril; 2010 Nov; 94(6):2427-9. PubMed ID: 20307878
[TBL] [Abstract][Full Text] [Related]
42. [Impact of controlled ovarian hyperstimulation delayed, which occurs after functionally pituitary downregulation by depot GnRH agonist, on the outcome of in vitro fertilization and embryo transfer].
Ma QH; Li SW; Huang ZY; Han ZY; Qiu DS; Han DW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):980-3. PubMed ID: 18095601
[TBL] [Abstract][Full Text] [Related]
43. Poor responders in IVF: an update in therapy.
Giovanale V; Pulcinelli FM; Ralli E; Primiero FM; Caserta D
Gynecol Endocrinol; 2015 Apr; 31(4):253-7. PubMed ID: 25482873
[TBL] [Abstract][Full Text] [Related]
44. Modified super-long down-regulation protocol improved the outcome of in vitro fertilization-embryo transfer in infertile patients.
Gong F; Tang Y; Zhang H; Lu G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 34(3):185-9. PubMed ID: 19349670
[TBL] [Abstract][Full Text] [Related]
45. Gonadotropin-releasing hormone agonist/antagonist conversion with estrogen priming in low responders with prior in vitro fertilization failure.
Fisch JD; Keskintepe L; Sher G
Fertil Steril; 2008 Feb; 89(2):342-7. PubMed ID: 17562336
[TBL] [Abstract][Full Text] [Related]
46. Comparison of mild and microdose GnRH agonist flare protocols on IVF outcome in poor responders.
Karimzadeh MA; Mashayekhy M; Mohammadian F; Moghaddam FM
Arch Gynecol Obstet; 2011 May; 283(5):1159-64. PubMed ID: 21221982
[TBL] [Abstract][Full Text] [Related]
47. A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years.
D'Amato G; Caroppo E; Pasquadibisceglie A; Carone D; Vitti A; Vizziello GM
Fertil Steril; 2004 Jun; 81(6):1572-7. PubMed ID: 15193479
[TBL] [Abstract][Full Text] [Related]
48. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
[TBL] [Abstract][Full Text] [Related]
49. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis.
Kyrou D; Kolibianakis EM; Venetis CA; Papanikolaou EG; Bontis J; Tarlatzis BC
Fertil Steril; 2009 Mar; 91(3):749-66. PubMed ID: 18639875
[TBL] [Abstract][Full Text] [Related]
50. Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized study.
Escribá MJ; Bellver J; Bosch E; Sánchez M; Pellicer A; Remohí J
Fertil Steril; 2006 Jul; 86(1):92-7. PubMed ID: 16818032
[TBL] [Abstract][Full Text] [Related]
51. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization.
Morgia F; Sbracia M; Schimberni M; Giallonardo A; Piscitelli C; Giannini P; Aragona C
Fertil Steril; 2004 Jun; 81(6):1542-7. PubMed ID: 15193474
[TBL] [Abstract][Full Text] [Related]
52. Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulation.
Doody KJ; Schnell VL; Foulk RA; Miller CE; Kolb BA; Blake EJ; Yankov VI
Fertil Steril; 2009 Apr; 91(4):1012-7. PubMed ID: 18371963
[TBL] [Abstract][Full Text] [Related]
53. Evaluation and treatment of low responders.
Scott RT
Semin Reprod Endocrinol; 1996 Nov; 14(4):317-37. PubMed ID: 8988527
[TBL] [Abstract][Full Text] [Related]
54. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing their first treatment cycle of IVF or ICSI.
Bjercke S; Tanbo T; Abyholm T; Omland A; Opøien HK; Fedorcsak P
Acta Obstet Gynecol Scand; 2010 Aug; 89(8):1053-60. PubMed ID: 20602599
[TBL] [Abstract][Full Text] [Related]
55. Does luteal estradiol supplementation have a role in long agonist cycles?
Elgindy EA; El-Haieg DO; Mostafa MI; Shafiek M
Fertil Steril; 2010 May; 93(7):2182-8. PubMed ID: 19243745
[TBL] [Abstract][Full Text] [Related]
56. The effectiveness of transdermal testosterone gel 1% (androgel) for poor responders undergoing in vitro fertilization.
Doan HT; Quan LH; Nguyen TT
Gynecol Endocrinol; 2017 Dec; 33(12):977-979. PubMed ID: 28562099
[TBL] [Abstract][Full Text] [Related]
57. Effects of salpingectomy on ovarian response in controlled ovarian hyperstimulation for in vitro fertilization: a reappraisal.
Almog B; Wagman I; Bibi G; Raz Y; Azem F; Groutz A; Barkan G; Holzer H; Amit A; Tulandi T; Levin I
Fertil Steril; 2011 Jun; 95(8):2474-6. PubMed ID: 21474129
[TBL] [Abstract][Full Text] [Related]
58. A prospective, randomized, controlled trial comparing three different gonadotropin regimens in oocyte donors: ovarian response, in vitro fertilization outcome, and analysis of cost minimization.
Melo M; Bellver J; Garrido N; Meseguer M; Pellicer A; Remohí J
Fertil Steril; 2010 Aug; 94(3):958-64. PubMed ID: 19931075
[TBL] [Abstract][Full Text] [Related]
59. The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen.
Morgante G; Orvieto R; Di Sabatino A; Musacchio MC; De Leo V
Fertil Steril; 2011 Jun; 95(8):2642-4. PubMed ID: 21300338
[TBL] [Abstract][Full Text] [Related]
60. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
Costello MF; Hughes GJ; Garrett DK; Hanjani A; Steigrad SJ
Int J Fertil Womens Med; 1998; 43(1):28-33. PubMed ID: 9532467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
